Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 11, 2004, Pages 5454-5461

  Talbott, E O ^a   Zborowski, J V ^a   Rager, J R ^a   Boudreaux, M Y ^a   Edmundowicz, D A ^b   Guzick, D S ^c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ARTERY CALCIFICATION; ARTICLE; BODY MASS; CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ELECTRON BEAM TOMOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC DISORDER; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AORTIC DISEASES; CALCINOSIS; CORONARY DISEASE; FEMALE; HUMANS; METABOLIC SYNDROME X; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 8744260883     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032237     Document Type: Article

References (47)

1. Dunaif A 1995 Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med 98:33S-39S
2. Franks S, Gilling-Smith C, Watson H, Willis D 1999 Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 28:361-378
3. Franks S, Mason H, White D, Willis D 1998 Etiology of anovulation in polycystic ovary syndrome. Steroids 63:306-307
4. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146
5. Legro RS, Kunselman AR, Dunaif A 2001 Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111:607-613
6. Wild S, Pierpoint T, McKeigue P, Jacobs H 2000 Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 52:595-600
7. Mather KJ, Kwan F, Corenblum B 2000 Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril 73:150-156
8. Mattsson LA, Cullberg G, Hamberger L, Samsioe G, Silfverstolpe G 1984 Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease. Fertil Steril 42: 579-584
9. Wild RA, Painter PC, Coulson PB, Carruth KB, Ranney GB 1985 Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 61:946-951
10. Pasquali R, Venturoli S, Paradisi R, Capelli M, Parenti M, Melchionda N 1982 Insulin and C-peptide levels in obese patients with polycystic ovaries. Horm Metab Res 14:284-287
11. Chang RJ, Nakamura RM, Judd HL, Kaplan SA 1983 Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57:356-359
12. Slowinska-Srzednicka J, Zgliczynski S, Wierzbicki M, Srzednicki M, Stopinska-Gluszak U, Zgliczynski W, Soszynski P, Chotkowska E, Bednarska M, Sadowski Z 1991 The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest 14:569-575
13. Wild RA, Alaupovic P, Givens JR, Parker IJ 1992 Lipoprotein abnormalities in hirsute women. II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity. Am J Obstet Gynecol 167:1813-1818
14. Wild RA, Alaupovic P, Parker IJ 1992 Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance. Am J Obstet Gynecol 166:1191-1197
15. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS 1992 Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 37:119-125
16. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A 1992 Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71:599-604
17. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, Mattson LA, Crona N, Lundberg PA 1992 Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 57:505-513
18. Talbott E, Clerici A, Berga SL, Kuller L, Guzick D, Detre K, Daniels T, Engberg RA 1998 Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol 51:415-422
19. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D 1992 Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326:381-386
20. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX 1997 Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 146:483-494
21. Guzick DS 1996 Cardiovascular risk in women with polycystic ovarian syndrome. Semin Reprod Endocrinol 14:45-49
22. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE, Kuller LH 2000 Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20:2414-2421
23. Kuller LH, Matthews KA, Sutton-Tyrrell K, Edmundowicz D, Bunker CH 1999 Coronary and aortic calcification among women 8 years after menopause and their premenopausal risk factors: the healthy women study. Arterioscler Thromb Vasc Biol 19:2189-2198
24. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson Jr SK 1999 Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14-22
25. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, Baron AD 2001 Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103:1410-1415
26. Birdsall MA, Farquhar CM, White HD 1997 Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med 126:32-35
27. Elting MW, Korsen TJ, Bezemer PD, Schoemaker J 2001 Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population. Hum Reprod 16:556-560
28. McKeigue P 1996 Cardiovascular disease and diabetes in women with polycystic ovary syndrome. Baillieres Clin Endocrinol Metab 10:311-318
29. Wild RA 2002 Long-term health consequences of PCOS. Hum Reprod Update 8:231-241
30. Detrano RC, Wong ND, Doherty TM, Shavelle R 1997 Prognostic significance of coronary calcific deposits in asymptomatic high-risk subjects. Am J Med 102:344-349
31. Arad Y, Spadaro LA, Goodman K, Lledo-Perez A, Sherman S, Lerner G, Guerci AD 1996 Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects. Circulation 93:1951-1953
32. Janowitz WR 2001 CT imaging of coronary artery calcium as an indicator of atherosclerotic disease: an overview. J Thorac Imaging 16:2-7
33. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS 1995 Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 92:2157-2162
34. Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy Jr PF, Fitzpatrick LA 2003 Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2562-2568
35. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, Kuller L 1995 Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821-826
36. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC 1974 Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475
37. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
38. Bucolo G, David H 1973 Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476-482
39. Adult Treatment Panel III 2002 Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection E, and Treatment of High Cholesterol in Adults (Adult Treatment Panel III) final report. Bethesda, MD: NIH, Department of Health and Human Services. NIH publication 02-5215
40. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte Jr M, Detrano R 1990 Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827-832
41. Wolfe ML, Iqbal N, Gefter W, Mohler III ER, Rader DJ, Reilly MP 2002 Coronary artery calcification at electron beam computed tomography is increased in asymptomatic type 2 diabetics independent of traditional risk factors. J Cardiovasc Risk 9:369-376
42. Arad Y, Newstein D, Cadet F, Roth M, Guerci AD 2001 Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol 21:2051-2058
43. Schurgin S, Rich S, Mazzone T 2001 Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care 24:335-338
44. Meigs JB, Larson MG, D'Agostino RB, Levy D, Clouse ME, Nathan DM, Wilson PW, O'Donnell CJ 2002 Coronary artery calcification in type 2 diabetes and insulin resistance: the Framingham offspring study. Diabetes Care 25: 1313-1319
45. Hanke H, Lenz C, Hess B, Spindler KD, Weidemann W 2001 Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall. Circulation 103:1382-1385
46. Tep-areenan P, Kendall DA, Randall MD 2003 Mechanisms of vasorelaxation to testosterone in the rat aorta. Eur J Pharmacol 465:125-132
47. Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, Pols HA 2002 Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 87:3632-3639